Loading...
Loading...
Browse all stories on DeepNewz
VisitStudy Links Puberty Blockers to 26.5x Higher Testicular Cancer Risk
Nov 24, 2024, 01:49 AM
New evidence suggests that long-term treatment with puberty blockers and cross-sex hormones may significantly increase the risk of testicular cancer. A study involving 458 men found that they are 26.5 times more likely to develop testicular cancer after undergoing such treatments. Testicular cancer rates are 26.5x HIGHER in males seeking orchiectomies. This raises serious concerns about the safety and ethical implications of using these treatments in young individuals.
View original story
Markets
Yes • 50%
No • 50%
Official announcements from the FDA or major health news outlets
No • 50%
Yes • 50%
Legal filings or reports from major news outlets
No • 50%
Yes • 50%
Statements or publications from major medical associations like the American Medical Association or American Academy of Pediatrics
Other • 25%
Implement new regulations • 25%
Conduct further research • 25%
No action taken • 25%
Official government statements or policy changes reported by credible news sources
Increased concern • 25%
No significant change • 25%
Other • 25%
Decreased concern • 25%
Public opinion polls or surveys conducted by reputable organizations
No changes • 25%
Other • 25%
Issue warning • 25%
Update guidelines • 25%
Reports from public health agencies or major health news outlets